Palo Alto Investors Has Raised By $469,722 Its Alexion Pharmaceuticals (ALXN) Stake; DNP Select Income Fund (DNP) Has 1.61 Sentiment

October 13, 2017 - By Migdalia James

DNP Select Income Fund Inc. is a closed-end diversified management investment company. The company has market cap of $3.30 billion. The Fund’s primary investment objectives are current income and long-term growth of income. It has a 30.06 P/E ratio. Capital appreciation is a secondary objective.

Palo Alto Investors Llc increased Alexion Pharmaceuticals Inc (ALXN) stake by 0.38% reported in 2017Q2 SEC filing. Palo Alto Investors Llc acquired 3,882 shares as Alexion Pharmaceuticals Inc (ALXN)’s stock declined 11.63%. The Palo Alto Investors Llc holds 1.03M shares with $125.44 million value, up from 1.03M last quarter. Alexion Pharmaceuticals Inc now has $31.57B valuation. The stock declined 0.02% or $0.03 reaching $141.43 on the news. About 125,405 shares traded. Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) has declined 18.12% since October 13, 2016 and is downtrending. It has underperformed by 34.82% the S&P500.

Among 27 analysts covering Alexion Pharmaceuticals Inc. (NASDAQ:ALXN), 21 have Buy rating, 0 Sell and 6 Hold. Therefore 78% are positive. Alexion Pharmaceuticals Inc. had 78 analyst reports since July 27, 2015 according to SRatingsIntel. On Thursday, December 22 the stock rating was maintained by RBC Capital Markets with “Outperform”. On Friday, July 28 the stock rating was maintained by Morgan Stanley with “Buy”. The rating was maintained by Robert W. Baird on Friday, June 23 with “Hold”. Jefferies maintained Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) on Friday, September 23 with “Hold” rating. Barclays Capital maintained Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) on Thursday, February 4 with “Equal-Weight” rating. Barclays Capital upgraded the stock to “Overweight” rating in Tuesday, November 29 report. The firm has “Overweight” rating by JP Morgan given on Monday, July 27. The firm earned “Outperform” rating on Monday, September 26 by Leerink Swann. Stifel Nicolaus maintained it with “Buy” rating and $165.0 target in Tuesday, September 12 report. The firm has “Overweight” rating by JP Morgan given on Tuesday, September 5.

Investors sentiment increased to 1.37 in 2017 Q2. Its up 0.23, from 1.14 in 2017Q1. It increased, as 55 investors sold ALXN shares while 146 reduced holdings. 72 funds opened positions while 203 raised stakes. 208.01 million shares or 0.31% less from 208.67 million shares in 2017Q1 were reported. Dnb Asset Management As reported 0% stake. Delta Asset Mgmt Lc Tn has invested 0% in Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN). National Bank Of Mellon invested in 0.11% or 3.35M shares. Cwm Ltd Llc reported 43 shares. Bb Biotech Ag holds 1.35 million shares or 5.04% of its portfolio. Lombard Odier Asset Management (Europe) Limited reported 2,794 shares. Td Asset Mngmt has invested 0.08% in Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN). State Of Wisconsin Invest Board invested in 265,316 shares or 0.1% of the stock. First Personal Fincl Service holds 0.01% or 193 shares in its portfolio. Norinchukin National Bank & Trust The holds 0.04% or 15,584 shares. Federated Pa reported 630,864 shares. Comerica Secs reported 2,394 shares stake. Nj State Employees Deferred Compensation Plan invested in 0.28% or 12,000 shares. Sumitomo Mitsui Holdg Inc invested 0.11% of its portfolio in Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN). Everence Mngmt Incorporated stated it has 4,425 shares or 0.13% of all its holdings.

Since June 14, 2017, it had 4 insider buys, and 1 sale for $235.75 million activity. Shares for $77.53M were bought by BAKER BROS. ADVISORS LP. PARVEN ALVIN S also sold $97,511 worth of Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) shares. Shares for $1.17 million were bought by HANTSON LUDWIG. COUGHLIN CHRISTOPHER J bought $234,200 worth of stock or 2,000 shares.

Aviance Capital Partners Llc holds 0.9% of its portfolio in DNP Select Income Fund Inc. for 252,835 shares. Bennicas & Associates Inc. owns 85,769 shares or 0.85% of their US portfolio. Moreover, Livingston Group Asset Management Co (Operating As Southport Capital Management) has 0.64% invested in the company for 131,498 shares. The Missouri-based Monetary Management Group Inc has invested 0.31% in the stock. Legacy Capital Partners Inc., a Wisconsin-based fund reported 45,300 shares.

It is down 9.00% since October 13, 2016 and is uptrending. It has underperformed by 7.70% the S&P500.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:

Twitter Auto Publish Powered By :